Oocyte and Embryo Vitrification Warming
Materials Required
Principle
Oocyte and embryo vitrification warming reverses ice-free cryopreservation by rapidly warming vitrified specimens and diluting permeating cryoprotectants through sucrose-containing solutions to reduce osmotic injury; successful warming is assessed by post-warming survival, oocyte membrane integrity, embryo blastomere survival, blastocyst re-expansion, and subsequent developmental competence[1][2][3][4]. Rapid warming is a critical technical principle because mouse oocyte experiments showed survival depended strongly on warming rate and recrystallization control, while human protocols commonly place vitrified oocytes or embryos directly into pre-warmed sucrose solution before stepwise dilution[5][6][7].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use culture/base medium supplemented as reported by the selected protocol, permeating cryoprotectant residues expected from vitrification solutions such as ethylene glycol and DMSO, and sucrose-containing warming/dilution solutions commonly reported at 1.0 M, 0.5 M, and 0.25 M sucrose for stepwise rehydration[1][4][6][7].
• Outcomes are evaluated morphologically by survival, re-expansion, fertilization, cleavage, blastocyst formation, or transfer-related endpoints[1][2][3][4][7].
• Use a stereomicroscope or inverted microscope for specimen handling and survival assessment, warmed stage or 37 °C warming environment where specified, liquid-nitrogen storage devices/carriers, sterile handling pipettes, warming dishes or wells, and an incubator for post-warming recovery and embryo culture[1][2][3][6][7].
• Outcomes are evaluated morphologically by survival, re-expansion, fertilization, cleavage, blastocyst formation, or transfer-related endpoints[1][2][3][4][7].
• Use a stereomicroscope or inverted microscope for specimen handling and survival assessment, warmed stage or 37 °C warming environment where specified, liquid-nitrogen storage devices/carriers, sterile handling pipettes, warming dishes or wells, and an incubator for post-warming recovery and embryo culture[1][2][3][6][7].
Experimental Procedure
• Prepare warming and dilution drops before removing the carrier from liquid nitrogen; human oocyte studies commonly used immediate warming in 1.0 M sucrose at 37 °C, followed by stepwise dilution in lower sucrose concentrations, and one study compared room-temperature versus 37 °C rehydration after the first 37 °C warming step[6][7].
• Confirm specimen identity, developmental stage, and carrier type before warming; published studies include mature MII oocytes, cleavage-stage embryos, blastocysts, and zygotes, and carrier systems influence handling volume, cooling/warming rate, and traceability[1][3][4][8].
• Remove the vitrification carrier from liquid nitrogen and immediately immerse the vitrified oocyte or embryo into 1.0 M sucrose warming solution at 37 °C; reported exposure times include 60 seconds for human oocytes and zygotes and 1 minute for human vitrified-warmed oocytes[4][6][7].
• Transfer the specimen into 0.5 M sucrose dilution solution for 3 minutes, then into 0.25 M sucrose dilution solution for 3 minutes when using the three-step rehydration scheme reported for human oocytes[7].
• Wash the specimen in cryoprotectant-free culture or washing medium; reported wash conditions include two 3-minute washes for human oocytes after sucrose dilution and 5 minutes in cryoprotectant-free solution for human oocytes and zygotes in a closed-carrier protocol[4][7].
• After warming and washing, incubate oocytes before insemination or ICSI when required by the study design, and culture embryos or blastocysts to assess survival, cleavage, compaction, blastocyst formation, or re-expansion according to developmental stage[1][2][3][4][7].
• For oocytes, score survival by intact membrane morphology after warming and record fertilization, cleavage, blastocyst development, or other post-warming competence endpoints when the experimental design includes insemination or ICSI[1][2][6][7].
• For embryos, score post-warming survival by blastomere integrity or blastocyst re-expansion and continue culture when the study endpoint requires developmental competence assessment[1][3][4][8].
• Use non-vitrified or fresh oocytes/embryos as controls when comparing developmental competence, and use protocol-comparison groups when testing warming temperature, sucrose dilution design, carrier format, or handling-volume changes[2][3][6][7][8].
• Confirm specimen identity, developmental stage, and carrier type before warming; published studies include mature MII oocytes, cleavage-stage embryos, blastocysts, and zygotes, and carrier systems influence handling volume, cooling/warming rate, and traceability[1][3][4][8].
• Remove the vitrification carrier from liquid nitrogen and immediately immerse the vitrified oocyte or embryo into 1.0 M sucrose warming solution at 37 °C; reported exposure times include 60 seconds for human oocytes and zygotes and 1 minute for human vitrified-warmed oocytes[4][6][7].
• Transfer the specimen into 0.5 M sucrose dilution solution for 3 minutes, then into 0.25 M sucrose dilution solution for 3 minutes when using the three-step rehydration scheme reported for human oocytes[7].
• Wash the specimen in cryoprotectant-free culture or washing medium; reported wash conditions include two 3-minute washes for human oocytes after sucrose dilution and 5 minutes in cryoprotectant-free solution for human oocytes and zygotes in a closed-carrier protocol[4][7].
• After warming and washing, incubate oocytes before insemination or ICSI when required by the study design, and culture embryos or blastocysts to assess survival, cleavage, compaction, blastocyst formation, or re-expansion according to developmental stage[1][2][3][4][7].
• For oocytes, score survival by intact membrane morphology after warming and record fertilization, cleavage, blastocyst development, or other post-warming competence endpoints when the experimental design includes insemination or ICSI[1][2][6][7].
• For embryos, score post-warming survival by blastomere integrity or blastocyst re-expansion and continue culture when the study endpoint requires developmental competence assessment[1][3][4][8].
• Use non-vitrified or fresh oocytes/embryos as controls when comparing developmental competence, and use protocol-comparison groups when testing warming temperature, sucrose dilution design, carrier format, or handling-volume changes[2][3][6][7][8].
Troubleshooting
Problem: Low post-warming survival.
• Possible Cause: Warming was not sufficiently rapid or specimens remained too long in the critical temperature range.• Literature-supported Solution: Transfer specimens directly from liquid nitrogen into pre-warmed sucrose solution and prioritize rapid warming conditions, because warming rate strongly affected vitrified mouse oocyte survival and human studies used immediate 37 °C sucrose warming[5][6][7].
Problem: Oocyte swelling or lysis during rehydration.
• Possible Cause: Osmotic dilution of cryoprotectants occurred too abruptly.• Literature-supported Solution: Use stepwise sucrose dilution, such as 1.0 M sucrose followed by 0.5 M and 0.25 M sucrose, as reported in human oocyte warming studies[6][7].
Problem: Inconsistent survival between operators or runs.
• Possible Cause: Variation in timing and direct handling during movement between cryoprotectant and warming solutions.• Literature-supported Solution: Standardize timing, minimize handling steps where validated, and maintain traceability, because device-based nanoliter vitrification was developed to reduce handling variation and preserve viability comparable to standard practice[8].
References:
- [1]. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007;67(1):73-80. [Content Brief]
- [2]. Liebermann J, et al. Effect of carrier system on the yield of human oocytes and embryos as assessed by survival and developmental potential after vitrification. Reproduction. 2002;124(4):483-489. [Content Brief]
- [3]. Practice Committee of the American Society for Reproductive Medicine; Society for Reproductive Biologists and Technologists. A review of best practices of rapid-cooling vitrification for oocytes and embryos: a committee opinion. Fertil Steril. 2021;115(2):305-310. [Content Brief]
- [4]. Gallardo M, et al. Human oocytes and zygotes are ready for ultra-fast vitrification after 2 minutes of exposure to standard CPA solutions. Sci Rep. 2019;9(1):15986. [Content Brief]
- [5]. Seki S, et al. Effect of warming rate on the survival of vitrified mouse oocytes and on the recrystallization of intracellular ice. Biol Reprod. 2008;79(4):727-737. [Content Brief]
- [6]. De Munck N, et al. Survival and post-warming in vitro competence of human oocytes after high security closed system vitrification. J Assist Reprod Genet. 2013;30(3):361-369. [Content Brief]
- [7]. Shanshan G, et al. Effect of different rehydration temperatures on the survival of human vitrified-warmed oocytes. J Assist Reprod Genet. 2015;32(8):1197-1203. [Content Brief]
- [8]. Yagoub SH, Lim M, Tan TCY, Chow DJX, Dholakia K, Gibson BC, et al. Vitrification within a nanoliter volume: oocyte and embryo cryopreservation within a 3D photopolymerized device. J Assist Reprod Genet. 2022;39(9):1997-2014. [Content Brief]
LinkedIn
Researchgate
Instagram
X
Facebook
WhatsApp
Reddit
Mail